This study was performed to investigate the anti-obesity effect of Eisenia bicyclis in mice fed a high-fat diet (HFD). Male C57BL/6J mice were divided into three groups that were fed a normal diet, an HFD, or an HFD supplemented with a 5% powder of Eisenia bicyclis (PEB) for 8 weeks. The PEB group showed lower body weight gains than the HFD group. The PEB group also exhibited reduced body fat mass and adipose cell size in epididymal adipose tissue. The concentrations of serum cholesterol, leptin, and insulin in the PEB group were significantly lower than those in the HFD group. Liver triglyceride content was significantly decreased by PEB supplementation. Furthermore, hematoxylin and eosin staining revealed that PEB supplementation reduced lipid droplet formation in the liver induced by HFD. These results suggest that PEB supplementation reduces body weight gain and fat accumulation in HFD-induced obese mice.
INTRODUCTION
Obesity is mainly caused by an imbalance between intake and expenditure of energy and is a major risk factor for diseases and conditions, including type II diabetes, hypertension, cardiovascular morbidity, premature mortality, degenerative arthritis, and myocardial infarction, as well as psychological factors including anger, anxiety, and depression (1, 2) . The obese population has been increasing worldwide, and obesity is now considered a major health and economic concern in many countries.
Over the past few centuries, many studies have been conducted to identify novel anti-obesity agents that can reduce and/or regulate total cholesterol and triglyceride content from synthetic and natural sources. Given their numerous biological and phytochemical benefits, marine plants are currently interesting sources of nutraceuticals and pharmaceuticals (3) . Eisenia bicyclis is a common perennial brown alga belonging to the family Laminariaceae that inhabits the middle Pacific coast around Korea and Japan. Laminarin from Eisenia bicyclis is an oligosaccharide composed of β-(1→3)-linked glucose residues with small amounts of β-(1→6) linkages as interresidue linkages or branch points (4, 5) . This structural laminarin is believed to have biological activities that modulate the immune response (6) such as antitumor (7) and anti-apoptosis effects (8) . Therefore, in this study we have evaluated the potential of Eisenia bicyclis as an anti-obesity and hypolipidemic agent in a high-fat diet (HFD)-induced obesity model.
MATERIALS AND METHODS

Preparation of powder of Eisenia bicyclis
Eisenia bicyclis obtained from Gyeongbuk Institute for Marine Bio-Industry were washed and dried by using a freeze drier (Ilshin, Gyeonggi, Korea). Then, they were cut into small chips, powdered by passing through 80 mesh sieves, and stored at -20 o C prior to use.
Animals and diets
Male C57BL/6J mice (4 weeks of age) were purchased from Orient Bio Inc. (Gyeonggi, Korea) and allowed free access to commercial chow for 7 days. After acclimation, the mice were divided randomly into three groups and maintained for 8 weeks on a normal diet (NOR, n=10), an HFD (n=10), or an HFD supplemented with a 5% powder of Eisenia bicyclis (PEB, n=10). The experimental diets were based on the AIN-76 diet, and the HFD was prepared by supplementing the basal AIN-76 diet with 20% fat and 0.5% cholesterol (w/w). The compositions of the experimental diets are listed in Table  1 . Animals were maintained at 21∼25 o C with a humidity of 50∼60% under a 12-hr light:dark cycle (lights 
Sample preparation
After consuming the experimental diets for 8 weeks, the mice were allowed to fast for 12 hr and then sacrificed under diethyl ether anesthesia. Blood was collected and centrifuged at 1500 × g for 20 min to separate the serum, which was stored at -70 o C until analysis. The livers and epididymal and perirenal fat pads were excised, weighed, and stored at -70 o C until use.
Serum analysis
Triglyceride, total cholesterol, and HDL-cholesterol levels were measured using a commercial enzyme kit (Eiken, Tokyo, Japan). LDL-cholesterol content was calculated as the difference between cholesterol and HDL-cholesterol. Insulin and leptin were analyzed using a mouse leptin immunoassay (R&D Systems, Minneapolis, MN, USA) and a mouse insulin immunoassay kit (Shibayagi, Gunma, Japan).
Hepatic lipid analysis
Hepatic lipid was extracted according to the method of Folch et al. (9) . Hepatic total cholesterol and triglycerides levels were measured using a commercial enzyme kit (Eiken).
Histological analysis
After the animals were sacrificed, liver and epididymal adipose tissues were removed and cut into small pieces. These tissues were fixed in 4% formaldehyde in phosphate-buffered solution, embedded in paraffin, sliced, and stained with hematoxylin and eosin (H&E; SigmaAldrich, St. Louis, MO, USA). The stained tissues were observed under a microscope (Olympus IX71, Tokyo, Japan) and photographed with a digital camera (Olympus DP71). Cellular size was measured using Image J software (National Institutes of Health, Bethesda, MD, USA).
Statistical analysis
Data were expressed as mean ± standard error of the mean. All statistical analyses were performed with analysis of variance (ANOVA) and Duncan's multiple range test by using the SPSS program, with a value of p<0.05 selected as the cutoff for statistical significance.
RESULTS AND DISCUSSION
Food intake, body weight, adipose tissue weight, and histology of adipose tissue
Feeding the HFD to the mice for 8 weeks increased the body weight gains significantly compared to those of mice in the NOR group, but feeding the HFD supplemented with PEB decreased the body weight gains significantly compared to those of mice in the HFD group (NOR, 8.12 ± 0.69 g; HFD, 17.75 ± 1.48 g; PEB, 11.02 ± 0.47 g; Table 2 ). There was no significant difference in food intake among the groups. These data indicate that PEB might have anti-obesity effects without affecting food intake. Adipose tissue is considered the biggest storage site for excess energy (10) . To test whether the body weight reduction observed in the PEB group was caused by decreases in adiposity, apididymal and perirenal fat pads were weighed and examined histologically (Fig. 1) . As shown in Fig. 1A , the weights of epididymal and perirenal adipose tissues in the HFD group were significantly increased by over 200% compared to those in the NOR group. However, the weights of adipose tissue in the PEB group were dramatically reduced. Obesity is typically characterized by excess body fat mass, and adipocytes are ultimately enlarged by obesity (11) . As shown in Fig. 1B , adipocytes of the HFD group appear to be remarkably larger than those of the NOR and PEB groups. Taken together, these results demonstrate that PEB has an anti-obesity effect in mice fed an HFD.
Lipid, insulin, and leptin profiles in serum
Obesity induced by high fat intake is usually accompanied by hyperlipidemia (12) , which presents as an abnormally high concentration of lipids in blood. Generally, this abnormally high concentration of lipids in blood indicates elevated total cholesterol or triglyceride levels in blood (13) . To examine whether alterations in adiposity by PEB supplementation are correlated with changes in serum levels of lipids, insulin, and leptin, blood samples were obtained from each group of mice. As shown in Table 3 , the total cholesterol level in the HFD group was increased by 59.5% compared with that in the NOR group. However, the total cholesterol level in the PEB group was significantly decreased relative to the level in the HFD group (NOR, 102.77 ± 1.85 mg/dL; HFD, 163.61 ± 7.61 mg/dL; PEB, 144.43 ± 6.96 mg/dL). LDLcholesterol level in the PEB group was also decreased compared to the HFD group (NOR, 17.14 ± 2.06 mg/dL; HFD, 57.13 ± 5.51 mg/dL; PEB, 45.45 ± 2.75 mg/dL). An elevated cholesterol level in serum is followed by hypercholesterolemia, and it is a major risk factor for atherosclerosis (14). Increased LDL-cholesterol level to the HDL-cholesterol is associated with high risk for the development of cardiovascular disease and atherosclerosis (15) . The results of this study suggest that PEB has a hypocholesterolemic effect in mice fed a HFD.
Adipose tissue regulates energy balance and glucose and lipid metabolism via the secretion of various adipokines such as leptin, adiponectin, and resistin. Leptin primarily controls appetite; however, overflow of leptin leads to insulin resistance and is a sign of obesity, as well as type II diabetes (16) . Hyperinsulinemia is also associated with obesity, metabolic syndrome, and insulin resistance (17) . Therefore, we investigated the effect of PEB on insulin and leptin levels in the serum. As shown in Table 3 , mice in the HFD group exhibited significant increases in the levels of insulin and leptin; however, these increased levels of insulin and leptin induced by the HFD were reduced significantly by PEB supplementation. In particular, the level of leptin in mice in the HFD group was more than 10-fold higher than that of mice in the NOR group. However, the leptin level in mice in the PEB group was maintained at a similar level to that of mice in the NOR group (NOR, 2.64 ± 1.12 ng/mL; HFD, 30.88 ± 7.69 ng/mL; PEB, 8.08 ± 2.64 ng/ mL). Many findings have revealed the relationship between leptin and adipose tissue (18) (19) (20) . Havel (18) reported that plasma leptin levels correlate with body fat content, and Drevon (20) also reported that increases in the size and number of fat cells are coupled with increased leptin secretion. This study also indicates that the effects of PEB on serum lipid, insulin, and leptin levels are consistent with the reduction in adipose cell size and fat tissue weight shown in Fig. 1 .
Hepatic lipid profiles and histology of liver
One of the most common characteristics of obesity is the development of a fatty liver or nonalcoholic steatohepatitis (NASH; 21, 22) . Therefore, the effect of PEB on fatty liver development induced by HFD was also analyzed in this study. First, the liver tissues were weighed. As shown in Table 4 , the liver weights of mice in the HFD group were dramatically increased compared to those of mice in the NOR group. However, the liver weights in mice in the PEB group were significantly reduced (NOR, 1.03 ± 0.02 g; HFD, 1.64 ± 0.15 g; PEB, 1.07 ± 0.02 g). In addition, the HFD group exhibited significant increases in total lipid, triglyceride, and total cholesterol levels in the liver compared to those of mice in the NOR group. Hepatic total cholesterol content in the PEB group was not decreased compared to that in the HFD group, although serum cholesterol was significantly decreased in the PEB group. This result is similar to a previous study that showed no differences in liver cholesterol observed between the high cholesterol diet group and the Alpinia pricei Hayata rhizome extract supplemented group (23) . However, when PEB was added to their diets, total lipid content in the livers of PEB group mice was lowered by 46.2% (NOR, 63.12 ± 3.45 mg/g; HFD, 139.47 ± 9.13 mg/g; PEB, 75.10 ± 1.63 mg/g), and triglyceride content in the livers of PEB group mice was lowered by 36.7% (NOR, 30.41 ± 1.12 mg/g; HFD, 57.91 ± 4.60 mg/g; PEB, 36.68 ± 1.76 mg/g) compared to those of the HFD group mice. These results were further confirmed by H&E staining of the hepatic tissues (Fig. 2) . In histological analyses, the livers of HFD-fed mice exhibited the accumulation of multiple fat droplets, a typical sign of fatty liver; however, a much smaller degree of lipid accumulation and lipid droplets was observed in the livers of PEB-supplemented mice. This result agrees with a previous study showing that high fatand cholesterol-containing diets induce hepatic cholesterol and triglyceride accumulation and result in an overweight liver (24) . Taken together, these results indicate that PEB might effectively improve lipid-related parameters in the liver.
In conclusion, this study suggests that PEB reduces body weight gain and fat accumulation in HFD-induced obese mice. Further research for mechanisms underlying the anti-obesity effect of PEB is required.
